Abstract:AIM: To investigate the expression of myofibrillogenesis regulator-1 (MR-1) in relation to clinicopathological parameters and postoperative survival in a group of Chinese patients with gastric cancer.METHODS: In our previous study of human whole-genome gene expression profiling, the differentially expressed genes were detected in the gastric cancer and its adjacent noncancerous mucosa. We found that MR-1 was associated with the location and differentiation of tumors. In this study, MR-1 protein expression was determined by immunohistochemistry in specimens of primary cancer and the adjacent noncancerous tissues from gastric cancer patients. A set of real-time quantitative polymerase chain reaction assays based on the Universal ProbeLibrary-a collection of 165 presynthesized, fluorescence-labeled locked nucleic acid hydrolysis probes-was designed specifically to detect the expression of MR-1 mRNA. The correlation was analyzed between the expression of MR-1 and other tumor characteristics which may influence the prognosis of gastric cancer patients. A retrospective cohort study on the prognosis was carried out and clinical data were collected from medical records.RESULTS: MR-1 mRNA and protein could be detected in gastric cancer tissues as well as in matched noncancerous tissues. MR-1 was up-regulated at both mRNA (5.459 +/- 0.639 vs 1.233 +/- 0.238, P < 0.001) and protein levels (34.2% vs 13.2%, P = 0.003) in gastric cancer tissues. Correlation analysis demonstrated that high expression of MR-1 in gastric cancer was significantly correlated with clinical stage (P = 0.034). Kaplan-Meier analysis showed that the postoperative survival of the MR-1 positive group tended to be poorer than that of the MR-1 negative group, and the difference was statistically significant (P = 0.002). Among all the patients with stage I-IV carcinoma, the 5-year survival rates of MR-1 positive and negative groups were 50.40% and 12.70%, respectively, with respective median survival times of 64.27 mo (95%CI: 13.41-115.13) and 16.77 mo (95%CI: 8.80-24.74). Univariate and multivariate analyses were performed to compare the impact of MR-1 expression and other clinicopathological parameters on prognosis. In a univariate analysis on all 70 specimens, 6 factors were found to be significantly associated with the overall survival statistically: including MR-1 expression, depth of invasion, distant metastasis, lymph node metastasis, vascular invasion and the tumor node metastasis (TNM) stage based on the 7th edition of the International Union against Cancer TNM classification. To avoid the influence caused by univariate analysis, the expressions of MR-1 as well as other parameters were examined in multivariate Cox analysis. Clinicopathological variables that might affect the prognosis of gastric cancer patients were analyzed by Cox regression analysis, which showed that MR-1 expression and TNM stage were independent predictors of postoperative survival. The best mathematical multivariate Cox regression model consisted of two factors: MR-1 expression and TNM stage. Our results indicated that MR-1 protein could act as an independent marker for patient overall survival [Hazard ratio (HR): 2.215, P = 0.043].CONCLUSION: MR-1 is an important variable that can be used to evaluate the outcome, prognosis and targeted therapy of gastric cancer patients. (C) 2012 Baishideng. All rights reserved.

Clinicopathology, Prognosis and EG-1 Mrna in Breast Cancer

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

Clinicopathological and related gene analysis in gastric adenocarcinoma and their correlation with prognosis

Expression of VEGF and Its Correlation with Prognosis of Small Cell Lung Cancer

Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma

Expressions and clinical significance of EGFR and EGFRv Ⅲ in mammary tumor

Expression of AEG-1-1 gene in NSCLC and its clinical significance

Clinicopathological And Prognostic Implications Of Arginase Expression In Hepatocellular Carcinoma

Expressions and clinical significance of EGFR and EGFRv III in mammary tumor

[The Relation Between Reg 1A Mrna Expression and the Clinicopathologic Parameters in the Patients with Primary Gastric Carcinoma].

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

[Study of Mrna Expression of Vascular Endothelial Growth Factor-(A, C, D) Genes and Its Effect on Prognosis of Breast Cancer].

Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer

Myofibrillogenesis Regulator-1 Overexpression is Associated with Poor Prognosis of Gastric Cancer Patients

Significance of breast cancer specific gene 1 expression in breast cancer

Expression of epidermal growth factor receptor in breast cancer - Its prognostic significance and relation with steroid hormone receptors

Expression of ZEB1 and Its Relationship with Prognosis in Breast Cancer

Clinicopathological Significance and Prognostic Analysis of P21 and EGFR in Colorectal Cancer: a Retrospective Analysis on 12 319 Cases in China

[The Effect of Breast Cancer Specific Gene 1 in the Prognosis of Breast Cancer].

ERCC1 is a potential biomarker for predicting prognosis, immunotherapy, chemotherapy efficacy, and expression validation in HER2 over-expressing breast cancer